Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTeva- Pharmaceutical Industries Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 6 | $0.43 | $0.51 | $0.47 |
| Q2 2026 | 7 | $0.57 | $0.61 | $0.60 |
| Q3 2026 | 7 | $0.48 | $0.52 | $0.50 |
| Q4 2026 | 3 | $0.71 | $0.76 | $0.73 |
| Q1 2027 | 3 | $0.60 | $0.64 | $0.62 |
| Q2 2027 | 2 | $0.70 | $0.74 | $0.72 |
| Q3 2027 | 2 | $0.83 | $0.88 | $0.85 |
| Q4 2027 | 2 | $0.87 | $0.92 | $0.89 |
Teva- Pharmaceutical Industries Ltd. Earnings Date And Information
Teva- Pharmaceutical Industries Ltd. last posted its earnings results on Wednesday, April 29th, 2026. The company reported $0.53 earnings per share for the quarter, topping analysts' consensus estimates of $0.5 by $0.03. The company had revenue of 3.98 B for the quarter and had revenue of 17.26 B for the year. Teva- Pharmaceutical Industries Ltd. has generated $1 earnings per share over the last year ($1.2 diluted earnings per share) and currently has a price-to-earnings ratio of 26.78. Teva- Pharmaceutical Industries Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Teva- Pharmaceutical Industries Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/29/2026 | Q1 2026 | $0.50 | $0.32 | -0.18 | $3.79 B | $3.98 B |
| 02/03/2026 | Q4 2025 | N/A | $0.42 | N/A | $4.32 B | $4.71 B |
| 11/05/2025 | Q3 2025 | $0.68 | $0.38 | -0.3 | $4.36 B | $4.48 B |
| 07/30/2025 | Q2 2025 | $0.63 | $0.25 | -0.38 | $4.27 B | $4.18 B |
| 05/07/2025 | Q1 2025 | $0.47 | $0.19 | -0.28 | $3.99 B | $3.89 B |
| 02/05/2025 | Q4 2024 | N/A | -$0.19 | N/A | $4.15 B | $4.23 B |
| 11/06/2024 | Q3 2024 | $0.65 | -$0.39 | -1.04 | $4.14 B | $4.33 B |
| 07/31/2024 | Q2 2024 | $0.57 | -$0.74 | -1.31 | $4.06 B | $4.16 B |
| 05/08/2024 | Q1 2024 | $0.51 | -$0.13 | -0.64 | $3.73 B | $3.82 B |
| 02/12/2024 | Q4 2023 | N/A | $0.41 | N/A | N/A | $4.46 B |
| 11/09/2023 | Q3 2023 | N/A | $0.07 | N/A | N/A | $3.85 B |
| 08/02/2023 | Q2 2023 | $0.54 | -$0.77 | -1.31 | N/A | $3.88 B |
| 05/10/2023 | Q1 2023 | $0.57 | -$0.20 | -0.77 | N/A | $3.66 B |
| 02/10/2023 | Q4 2022 | N/A | -$1.10 | N/A | N/A | $3.88 B |
| 11/03/2022 | Q3 2022 | $0.61 | $0.05 | -0.56 | N/A | $3.60 B |
| 07/27/2022 | Q2 2022 | N/A | -$0.21 | N/A | N/A | $3.79 B |
| 05/03/2022 | Q1 2022 | $0.55 | -$0.86 | -1.41 | N/A | $3.66 B |
| 02/09/2022 | Q4 2021 | $0.74 | -$0.14 | -0.88 | N/A | $4.10 B |
| 10/27/2021 | Q3 2021 | $0.65 | $0.26 | -0.39 | N/A | $3.89 B |
| 07/28/2021 | Q2 2021 | $0.57 | $0.19 | -0.38 | N/A | $3.91 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Teva- Pharmaceutical Industries Ltd. Earnings: FAQ's
In the previous quarter, Teva- Pharmaceutical Industries Ltd. (:TEVA) reported $0.53 earnings per share (EPS) to beat the analysts' consensus estimate of $0.5 by $0.03.
The conference call for Teva- Pharmaceutical Industries Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Teva- Pharmaceutical Industries Ltd.'s latest earnings report can be read online.
Teva- Pharmaceutical Industries Ltd. (:TEVA) has a recorded annual revenue of $17.26 B.
Teva- Pharmaceutical Industries Ltd. (:TEVA) has a recorded net income of $1.41 B.Teva- Pharmaceutical Industries Ltd. has generated $1.23 earnings per share over the last four quarters.
Teva- Pharmaceutical Industries Ltd. (:TEVA) has a price-to-earnings ratio of 26.78 and price/earnings-to-growth ratio is 0.01.